Cel-Sci
CVM
#10246
Rank
A$34.92 M
Marketcap
A$2.41
Share price
20.28%
Change (1 day)
-74.07%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -A$38.73 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$37.23 Million, an increase over its 2023 earnings that were of -A$42.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.73 Million4.04%
2024 -A$37.23 Million-12.41%
2023 -A$42.5 Million-12.87%
2022 -A$48.78 Million-3.42%
2021 -A$50.51 Million13.44%
2020 -A$44.53 Million11.28%
2019 -A$40.01 Million179.81%
2018 -A$14.3 Million-48.72%
2017 -A$27.89 Million-16.23%
2016 -A$33.29 Million-23.63%
2015 -A$43.59 Million-5.47%
2014 -A$46.11 Million198.49%
2013 -A$15.45 Million
2010 -A$18.04 Million
2004 -A$6.1 Million12.38%
2003 -A$5.43 Million-16.59%
2002 -A$6.51 Million-59.28%
2001 -A$15.97 Million23.17%
2000 -A$12.96 Million20.12%
1999 -A$10.79 Million13.24%
1998 -A$9.53 Million-20%
1997 -A$11.92 Million46.55%
1996 -A$8.13 Million34.88%
1995 -A$6.03 Million2.38%
1994 -A$5.89 Million68%
1993 -A$3.51 Million78.57%
1992 -A$1.97 Million180%
1991 -A$0.71 Million25%
1990 -A$0.57 Million-0%
1989 -A$0.57 Million-71.43%
1988 -A$1.97 Million-0%
1987 -A$1.97 Million-46.15%
1986 -A$3.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.40 B-105,014.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.73 B-36,797.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-A$0.2 Billion 457.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-A$45.63 Million 31.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.18 B-9,271.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
A$0.37 B-1,179.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-767.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.3 Million-61.68%๐Ÿ‡บ๐Ÿ‡ธ USA